Columbia University Medical Center SC LAG X2101C — New York, New York

Columbia University Medical Center SC LAG X2101C is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Columbia University Medical Center SC LAG X2101C has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumors.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia University Medical Center SC LAG X2101C?

Columbia University Medical Center SC LAG X2101C has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia University Medical Center SC LAG X2101C conducted?

Columbia University Medical Center SC LAG X2101C has 1 clinical trials on record. Their work covers Advanced Solid Tumors.

Is Columbia University Medical Center SC LAG X2101C accredited by Crixeo Health?

Columbia University Medical Center SC LAG X2101C has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Columbia University Medical Center SC LAG X2101C?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.